Search details
1.
The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination.
Cell
; 184(15): 3915-3935.e21, 2021 07 22.
Article
in English
| MEDLINE | ID: mdl-34174187
2.
Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans.
Cell
; 178(6): 1313-1328.e13, 2019 09 05.
Article
in English
| MEDLINE | ID: mdl-31491384
3.
Metabolic Phenotypes of Response to Vaccination in Humans.
Cell
; 169(5): 862-877.e17, 2017 May 18.
Article
in English
| MEDLINE | ID: mdl-28502771
4.
Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.
Nat Immunol
; 15(2): 195-204, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24336226
5.
Relationship of Heterologous Virus Responses and Outcomes in Hospitalized COVID-19 Patients.
J Immunol
; 211(8): 1224-1231, 2023 10 15.
Article
in English
| MEDLINE | ID: mdl-37756530
6.
A Phase 1, Double-blinded, Placebo-Controlled Clinical Trial to Evaluate the Safety and Immunogenicity of HEV-239 (Hecolin®) Vaccine in Healthy US Adults.
J Infect Dis
; 2024 Mar 27.
Article
in English
| MEDLINE | ID: mdl-38536442
7.
Influenza Vaccine Effectiveness Pre-pandemic Among Adults Hospitalized With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease and Older Adults.
Clin Infect Dis
; 78(4): 1065-1072, 2024 Apr 10.
Article
in English
| MEDLINE | ID: mdl-37946601
8.
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US Adults.
Clin Infect Dis
; 2024 Mar 27.
Article
in English
| MEDLINE | ID: mdl-38537255
9.
COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
Clin Infect Dis
; 2024 Apr 10.
Article
in English
| MEDLINE | ID: mdl-38598658
10.
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
N Engl J Med
; 384(5): 403-416, 2021 02 04.
Article
in English
| MEDLINE | ID: mdl-33378609
11.
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
N Engl J Med
; 384(9): 795-807, 2021 03 04.
Article
in English
| MEDLINE | ID: mdl-33306283
12.
Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures.
Immunity
; 43(6): 1186-98, 2015 Dec 15.
Article
in English
| MEDLINE | ID: mdl-26682988
13.
COVID-19 Vaccination Among Patients Receiving Maintenance Renal Replacement Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future.
J Infect Dis
; 228(Suppl 1): S46-S54, 2023 08 04.
Article
in English
| MEDLINE | ID: mdl-37539761
14.
A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults.
J Infect Dis
; 228(3): 287-298, 2023 08 11.
Article
in English
| MEDLINE | ID: mdl-36702771
15.
Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo.
J Infect Dis
; 2023 Nov 29.
Article
in English
| MEDLINE | ID: mdl-38019956
16.
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
J Infect Dis
; 228(12): 1662-1666, 2023 12 20.
Article
in English
| MEDLINE | ID: mdl-37561027
17.
Safety and Immunogenicity of Influenza A/H5N8 Virus Vaccine in Healthy Adults: Durability and Cross-reactivity of Antibody Responses.
Clin Infect Dis
; 2023 Jan 05.
Article
in English
| MEDLINE | ID: mdl-36610728
18.
Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group.
Clin Infect Dis
; 77(Suppl 4): S305-S313, 2023 10 16.
Article
in English
| MEDLINE | ID: mdl-37843118
19.
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
Clin Infect Dis
; 77(4): 560-564, 2023 08 22.
Article
in English
| MEDLINE | ID: mdl-37036397
20.
Persistent SARS-CoV-2-specific immune defects in kidney transplant recipients following third mRNA vaccine dose.
Am J Transplant
; 23(6): 744-758, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36966905